QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: dmd.107.018713v1 36/3/535    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gertz, M. Articles by Galetin, A. Search for Related Content PubMed PubMed Citation Articles by Gertz, M. Articles by Galetin, A. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Medicines

Drug Lipophilicity and Microsomal Protein Concentration as Determinants in the Prediction of the Fraction Unbound in Microsomal Incubations

School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester, United Kingdom

Two predictive tools have been proposed by Austin et al. (Drug Metab Dispos 30:1497–1503, 2002) and Hallifax and Houston (Drug Metab Dispos 34:724–726, 2006) to estimate the fraction unbound in the incubation (fu_inc). The current study was undertaken to elucidate the relative utility of these prediction tools over a range of drug lipophilicity and microsomal protein concentration. The fu_inc data set (n = 127) comprised 35 drugs determined experimentally in this study and 92 collated from Austin and Hallifax data. The observed fu_inc values at three microsomal concentrations were compared with the estimates obtained using the Austin and Hallifax equations. In addition, the impact of variability in the logP on the fu_inc predictions was assessed. The current analysis highlights the importance of accurate estimation of lipophilicity for the prediction of the fu_inc, regardless of the prediction equation used. Both equations represent useful tools for estimation of fu_inc for low lipophilicity drugs (logP/D = 0–3), especially at low microsomal protein concentration. However, the accuracy of fu_inc predictions of highly lipophilic drugs was poor for both equations, implying that fu_inc should be experimentally confirmed for drugs with logP/D 3, unless the microsomal protein concentration is as low as 0.1 mg/ml, in which case a cutoff of logP/D 5 can be applied. A significant difference in the predictions by the two proposed tools was observed in the area of intermediate lipophilicity (logP/D = 2.5–5), where the Hallifax equation provided more accurate fu_inc predictions on average, irrespective of the microsomal protein concentration investigated.

This article has been cited by other articles:

				P. J. Kilford, R. Stringer, B. Sohal, J. B. Houston, and A. Galetin Prediction of Drug Clearance by Glucuronidation from in Vitro Data: Use of Combined Cytochrome P450 and UDP-Glucuronosyltransferase Cofactors in Alamethicin-Activated Human Liver Microsomes Drug Metab. Dispos., January 1, 2009; 37(1): 82 - 89. [Abstract] [Full Text] [PDF]

				P. J. Kilford, M. Gertz, J. B. Houston, and A. Galetin Hepatocellular Binding of Drugs: Correction for Unbound Fraction in Hepatocyte Incubations Using Microsomal Binding or Drug Lipophilicity Data Drug Metab. Dispos., July 1, 2008; 36(7): 1194 - 1197. [Abstract] [Full Text] [PDF]